Uddrag fra ABG’s analyse af Penneo:
- DocuSign down 42% on COVID slowdown …
- … as billings and Q4 guidance fail to meet expectations
- Different geos and offerings, FVR DKK 20-37 (24-47)
Key peer DocuSign punished badly for billings and outlook
DocuSign traded down 42% on Friday after the release of its Q3 report. Billings (a leading indicator) and revenue guidance for Q4 missed FactSet cons. by 7% and 3%, respectively. The company sees slowing demand and less urgency in clients’ buying patterns as COVID tailwinds have turned more quickly than anticipated. Q4 billing guidance of 21-23% growth y-o-y is lower than pre-pandemic levels, which is due (according to management) to a necessary shift in sales focus from simply meeting excessive demand during the last six quarters to generating new demand.
Få vores øvrige investeringsnyheder direkte i din indbakke. Tilmeld dig vores gratis daglige nyhedsbrev her:
Tilmeld dig vores gratis nyhedsbrev
ØU Dagens Nyheder Middag - Investering
Vær et skridt foran. Få de vigtigste analyser af danske aktier og aktiemarkedet
Udkommer hver dag kl. 12.
